Gamal Badra

556 total citations
31 papers, 405 citations indexed

About

Gamal Badra is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Gamal Badra has authored 31 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 11 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Gamal Badra's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (8 papers). Gamal Badra is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (8 papers). Gamal Badra collaborates with scholars based in Egypt, Jordan and United Kingdom. Gamal Badra's co-authors include Mahmoud Lotfy, Samir El‐Masry, Faris Q Alenzi, Ahmed Massoud, Osama Salama, Tarek M. Mostafa, Nabil Hassan, Imam Waked, Tarek Salem and Mohamed F. El‐Refaei and has published in prestigious journals such as Gastroenterology, Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Gamal Badra

28 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gamal Badra Egypt 10 118 114 97 82 60 31 405
S Bunyaratvej Thailand 13 39 0.3× 98 0.9× 60 0.6× 106 1.3× 21 0.3× 30 436
Hongying Pan China 14 92 0.8× 76 0.7× 178 1.8× 12 0.1× 21 0.3× 49 552
Mabrouk Ghonaim Egypt 12 14 0.1× 36 0.3× 74 0.8× 19 0.2× 32 0.5× 34 378
Yeşim Çekın Türkiye 11 62 0.5× 79 0.7× 115 1.2× 89 1.1× 15 0.3× 36 397
Maged El-Ghannam Egypt 10 47 0.4× 90 0.8× 59 0.6× 125 1.5× 10 0.2× 28 311
Subhkij Angsubhakorn Thailand 7 20 0.2× 102 0.9× 25 0.3× 100 1.2× 6 0.1× 11 343
Ana María Rivas-Estilla Mexico 13 151 1.3× 34 0.3× 186 1.9× 7 0.1× 10 0.2× 31 498
Merve Aydın Türkiye 15 6 0.1× 58 0.5× 99 1.0× 94 1.1× 40 0.7× 46 478
Jiyuan Zhou China 14 167 1.4× 27 0.2× 158 1.6× 17 0.2× 6 0.1× 24 486
L Verbist Belgium 10 91 0.8× 53 0.5× 107 1.1× 9 0.1× 122 2.0× 13 461

Countries citing papers authored by Gamal Badra

Since Specialization
Citations

This map shows the geographic impact of Gamal Badra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamal Badra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamal Badra more than expected).

Fields of papers citing papers by Gamal Badra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gamal Badra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamal Badra. The network helps show where Gamal Badra may publish in the future.

Co-authorship network of co-authors of Gamal Badra

This figure shows the co-authorship network connecting the top 25 collaborators of Gamal Badra. A scholar is included among the top collaborators of Gamal Badra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gamal Badra. Gamal Badra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elsabaawy, Maha, et al.. (2025). Impact of age on frailty in liver cirrhosis: a prospective cohort study. Clinical and Experimental Medicine. 25(1). 203–203.
2.
Mostafa, Tarek M., et al.. (2021). Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study. Current Therapeutic Research. 95. 100654–100654. 5 indexed citations
3.
Gomaa, Asmaa, et al.. (2021). Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis. Journal of Hepatocellular Carcinoma. Volume 8. 925–935. 8 indexed citations
4.
Badra, Gamal, et al.. (2019). The Relationship between Interleukin-6 Polymorphism and Susceptibility to Hepatitis C-virus Infected Patients. Jordan Medical Journal. 53(1). 1 indexed citations
5.
Mostafa, Tarek M., et al.. (2015). The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients. The Turkish Journal of Gastroenterology. 26(2). 163–169. 30 indexed citations
6.
Badra, Gamal, et al.. (2015). Long-term effect of mass chemotherapy of Schistosoma mansoni on infection rate and diagnosis accuracy. International Journal of Infectious Diseases. 41. 79–82. 2 indexed citations
7.
Salama, Ibrahim, et al.. (2014). Iatrogenic Biliary Injuries: Multidisciplinary Management in a Major Tertiary Referral Center. HPB Surgery. 2014. 1–12. 9 indexed citations
8.
9.
Taylor‐Robinson, Simon D., Horace R. Williams, Mary M.E. Crossey, et al.. (2011). Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma. HPB. 13(6). 385–390. 26 indexed citations
10.
El‐Masry, Samir, et al.. (2010). Helicobacter pylori and Hepatitis C virus coinfection in Egyptian patients. Journal of Global Infectious Diseases. 2(1). 4–4. 30 indexed citations
11.
Badra, Gamal, et al.. (2010). Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients. Acta Microbiologica et Immunologica Hungarica. 57(1). 29–42. 26 indexed citations
12.
Badra, Gamal, et al.. (2008). S1947 MELD, Child Score, and Fibrosis Indices in Predicting Outcome of Acute Variceal Bleeding. Gastroenterology. 134(4). A–789.
13.
Badra, Gamal, et al.. (2006). Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV‐Genotype 4 Chronic Hepatitis. Journal of Immunology Research. 13(1). 11–15. 2 indexed citations
14.
Lotfy, Mahmoud, et al.. (2006). Distinct Serum Immunoglobulins Pattern in Egyptian Patients with Chronic HCV Infection Analyzed by Nephelometry. Journal of Immunoassay and Immunochemistry. 27(1). 103–114. 3 indexed citations
15.
El‐Masry, Samir, et al.. (2006). Serum laminin assayed by Slot-Blot-ELISA in patients with combined viral hepatitis C and schistosomiasis. Clinical Biochemistry. 39(6). 652–657. 5 indexed citations
16.
El‐Masry, Samir, et al.. (2004). Different cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.. PubMed. 11(1). 23–9. 8 indexed citations
17.
Elshal, Mohamed F., et al.. (2004). Role of concurrent S. mansoni infection in H. pylori-associated gastritis: a flow cytometric DNA-analysis and oxyradicals correlations. Clinica Chimica Acta. 346(2). 191–198. 8 indexed citations
18.
19.
Massoud, Ahmed, et al.. (2001). A safe, effective, herbal antischistosomal therapy derived from myrrh.. American Journal of Tropical Medicine and Hygiene. 65(6). 700–704. 89 indexed citations
20.
Badra, Gamal. (2000). Allopurinol vs octreotide in the prevention of post-ERCP pancreatitis in patients with biliary obstruction. A randomized controlled trial. The American Journal of Gastroenterology. 95(9). 2488–2488. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Bunyaratvej Breakdown of academic impact, for papers by Hongying Pan Breakdown of academic impact, for papers by Mabrouk Ghonaim Breakdown of academic impact, for papers by Yeşim Çekın Breakdown of academic impact, for papers by Maged El-Ghannam Breakdown of academic impact, for papers by Subhkij Angsubhakorn Breakdown of academic impact, for papers by Ana María Rivas-Estilla Breakdown of academic impact, for papers by Merve Aydın Breakdown of academic impact, for papers by Jiyuan Zhou Breakdown of academic impact, for papers by L Verbist
Rankless by CCL
2026